Mortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spain

dc.contributor.authorBerzosa Sánchez, Arantxa
dc.contributor.authorJiménez De Ory, Santiago
dc.contributor.authorFrick, M Antoinette
dc.contributor.authorMenasalvas Ruiz, Ana Isabel
dc.contributor.authorCouceiro, José Antonio
dc.contributor.authorMellado, Mª José
dc.contributor.authorBisbal, Otilia
dc.contributor.authorAlbendin Iglesias, Helena
dc.contributor.authorMontero, Marta
dc.contributor.authorRoca, Cristina
dc.contributor.authorSamperiz, Gloria
dc.contributor.authorCervero, Miguel
dc.contributor.authorMiralles, Celia
dc.contributor.authorFortuny Guash, Clàudia
dc.contributor.authorCarrasco, Itziar
dc.contributor.authorNavarro, María Luisa
dc.contributor.authorRamos Amador, José Tomás
dc.date.accessioned2025-11-19T09:32:04Z
dc.date.available2025-11-19T09:32:04Z
dc.date.created2021
dc.date.issued2021
dc.description.abstractIntroduction: After the introduction of combination antiretroviral treatment, (ART) mortality in HIV-infected patients has dramatically decreased. However, it is still high in patients at risk, as adolescents transitioning to adult care (AC) without virologic control. The aim of this study was to characterize mortality and comorbidities of perinatally infected HIV (PHIV) patients after transition to AC. Methods: A multicenter retrospective study from patients included in the CoRISpe-FARO Spanish cohort was conducted. PHIV patients who died after transition to AC between 2009 and 2019 were included. Clinical, immunovirologic characteristics, treatments received, comorbidities and causes of death were described. Results: Among 401 PHIV patients, 14 died (3.5%). All were Spanish, 11/14 (78.6%) women. The median age at diagnosis was 1.5 years (interquartile range [IQR] 0.5-3.9), at transfer to AC was 18 years [16.1-19.9] and at death was 25.8 years [23.6-27.1]. In pediatric units [pediatric care (PC)], CD4+ nadir was 85 cells/¿L [IQR 9.7-248.5] and 6/14 patients were classified as C-clinical stage. During AC, all patients were on C-clinical stage and CD4+ nadir dropped to 11.5 cells/¿L [4.5-43.3]. cART adherence was extremely poor: in PC, 8/14 patients registered voluntary treatment interruptions; only one had undetectable VL at transition. In AC, 12/14 patients stopped treatment 2 or more periods of time. All deaths were related to advanced HIV disease. Mental health disorders were observed in 7/14 (50%). Main complications described: recurrent bacterial infections (57.1%), wasting syndrome (42.9%), esophageal candidiasis (28.6%) and Pneumocystis jirovecii pneumonia (28.6%). Four women had 11 pregnancies; 5 children were born (none infected). Conclusions: Young adults PHIV infected who transition to AC without virologic suppression or proven ability to adhere to ART are at high risk of mortality. Mortality was noted as a consequence of advanced HIV disease, frequent mental health problems and poor adherence to ART.es_ES
dc.description.curso2021es_ES
dc.formatapplication/pdfes_ES
dc.identifier.dl2021
dc.identifier.locationN/Aes_ES
dc.identifier.urihttps://hdl.handle.net/20.500.12080/50983
dc.languageenges_ES
dc.publisherWolters Kluweres_ES
dc.rightsCopyrightes_ES
dc.rights.accessrightsinfo:eu-repo/semantics/closedAccesses_ES
dc.rights.uriN/Aes_ES
dc.sourceThe Pediatric Infectious Disease Journales_ES
dc.titleMortality in Perinatally HIV-infected Adolescents After Transition to Adult Care in Spaines_ES
dc.typeArtículoes_ES

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Restricciones Texto Completo.pdf
Size:
124.79 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.76 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections